The parasympathetic dysfunction as the risk factor for sudden cardiac death in patients with hypertrophic cardiomyopathy
✍ Scribed by S. Trzos; J.W. Kozlowski; M. Krzemińska-Pakula
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 151 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0300-9572
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A study of cardioprotection with ICRF-187 (Cardioxane, Eurocetus) has been performed in 35 patients with metastatic breast cancer treated with the FDC regimen (5-fluorouracil 500 mg/m 2 i.v., day 1; doxorubicin 50 mg/m 2 i.v., day 1; cyclophosphamide 500 mg/ m 2 i.v., day 1). All patients had one or
Liver transplantation offers good results in patients with small hepatocellular carcinoma. However, 3 to 15% of patients still have recurrence, suggesting that factors other than the size and number of nodules are implicated. The aim of our study was to identify predictive factors of recurrence in p
## Background: Although experimental studies have demonstrated an important role of insulin-like growth factor i (igf-i) in hepatocarcinogenesis, the clinical data about igf-i in patients with hepatocellular carcinoma (hcc) are scarce and controversial. to the authors' knowledge, this is the first